These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24551814)

  • 1. Drug Resistance of Pseudomonas aeruginosa and Enterobacter cloacae Isolated from ICU, Babol, Northern Iran.
    Bayani M; Siadati S; Rajabnia R; Taher AA
    Int J Mol Cell Med; 2013; 2(4):204-9. PubMed ID: 24551814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular detection of integron genes and pattern of antibiotic resistance in pseudomonas aeruginosa strains isolated from intensive care unit, shahid beheshti hospital, north of iran.
    Moradian Kouchaksaraei F; Ferdosi Shahandashti E; Molana Z; Moradian Kouchaksaraei M; Asgharpour F; Mojtahedi A; Rajabnia R
    Int J Mol Cell Med; 2012; 1(4):209-17. PubMed ID: 24551780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units.
    Pierson CL; Friedman BA
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2 Suppl):19S-30S. PubMed ID: 1737439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
    Zhanel GG; DeCorby M; Laing N; Weshnoweski B; Vashisht R; Tailor F; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; McCracken M; Mulvey MR; Johnson J; ; Hoban DJ
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1430-7. PubMed ID: 18285482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic Resistance of Pseudomonas aeruginosa in Pneumonia at a Single University Hospital Center in Germany over a 10-Year Period.
    Yayan J; Ghebremedhin B; Rasche K
    PLoS One; 2015; 10(10):e0139836. PubMed ID: 26430738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):443-8. PubMed ID: 24492025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic characterization of Pseudomonas aeruginosa-resistant isolates at the university teaching hospital in Iran.
    Fazeli H; Sadighian H; Esfahani BN; Pourmand MR
    Adv Biomed Res; 2015; 4():156. PubMed ID: 26380241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study.
    Motbainor H; Bereded F; Mulu W
    BMC Infect Dis; 2020 Jan; 20(1):92. PubMed ID: 32000693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001.
    Karlowsky JA; Draghi DC; Jones ME; Thornsberry C; Friedland IR; Sahm DF
    Antimicrob Agents Chemother; 2003 May; 47(5):1681-8. PubMed ID: 12709340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
    Ramadan MA; Tawfik AF; Shibl AM
    Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends and patterns in antimicrobial-resistant Gram-negative bacteria implicated in intensive care unit-acquired infections: A cohort-based surveillance study in Istanbul, Turkey.
    Durdu B; Kritsotakis EI; Lee ACK; Torun P; Hakyemez IN; Gultepe B; Aslan T
    J Glob Antimicrob Resist; 2018 Sep; 14():190-196. PubMed ID: 29751127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 2-Year Single-Centre Audit on Antibiotic Resistance of
    Feretzakis G; Loupelis E; Sakagianni A; Skarmoutsou N; Michelidou S; Velentza A; Martsoukou M; Valakis K; Petropoulou S; Koutalas E
    Antibiotics (Basel); 2019 May; 8(2):. PubMed ID: 31096587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016.
    Sader HS; Castanheira M; Shortridge D; Mendes RE; Flamm RK
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of the Strains of Multidrug-resistant, Extensively Drug-resistant, and Pandrug-resistant
    Hosseininassab Nodoushan SA; Yadegari S; Moghim S; Isfahani BN; Fazeli H; Poursina F; Nasirmoghadas P; Safaei HG
    Adv Biomed Res; 2017; 6():74. PubMed ID: 28706882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of antimicrobial susceptibility, class I and II integrons among Pseudomonas aeruginosa isolates from hospitalized patients in Isfahan, Iran.
    Faghri J; Nouri S; Jalalifar S; Zalipoor M; Halaji M
    BMC Res Notes; 2018 Nov; 11(1):806. PubMed ID: 30419962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gram-negative bacteria as causative agents of ventilator-associated pneumonia and their respective resistance mechanisms.
    Bandić-Pavlović D; Zah-Bogović T; Žižek M; Bielen L; Bratić V; Hrabač P; Slačanac D; Mihaljević S; Bedenić B
    J Chemother; 2020 Nov; 32(7):344-358. PubMed ID: 32729399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and risk factors of multidrug-resistant bacteria in respiratory samples after lung transplantation.
    Tebano G; Geneve C; Tanaka S; Grall N; Atchade E; Augustin P; Thabut G; Castier Y; Montravers P; Desmard M
    Transpl Infect Dis; 2016 Feb; 18(1):22-30. PubMed ID: 26455730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia.
    Sader HS; Castanheira M; Flamm RK; Mendes RE; Farrell DJ; Jones RN
    Int J Antimicrob Agents; 2015 Jul; 46(1):53-9. PubMed ID: 25956844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
    Orrett FA
    Saudi Med J; 2004 Apr; 25(4):478-83. PubMed ID: 15083220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.